Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

BOM/531015 stock hub

BOM/531015 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/531015is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

278M

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/531015

In the news

Latest news · BOM/531015

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E17.5

P25 n/aP50 n/aP75 n/a

ROE21.8

P25 n/aP50 n/aP75 n/a

ROIC-1.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/531015 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

INR

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2
Employees Change	-9%
Employees Change Percent	-81.82
Enterprise value	INR 296.9M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Medicinal Chemicals and Botanical Products
Last refreshed	2026-05-10
Market cap	INR 278M
Price	INR 24
Price currency	INR
Rev Per Employee	22,069,500x
Sic	2833
Symbol	bom/531015
Website	https://www.venmaxdrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.14%
EV Earnings	34.04x
EV/Sales	6.73x
P/B ratio	2.95x
P/E ratio	17.47x
P/S ratio	6.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.88%
EBITDA Margin	-3.78%
Gross margin	11.16%
Gross Profit	INR 4.9M
Net Income	INR 8.7M
Net Income Growth3 Y	-23.93%
Pretax Margin	20.4%
Profit Margin	19.76%
Profit Per Employee	INR 4.4M
ROA	-1.06
Roa5y	-37.75
ROCE	-1.82
ROE	21.82
ROIC	-1.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-11.84%
EPS Growth3 Y	-27.45
Revenue Growth	830.42x
Revenue Growth Q	679.27x
Revenue Growth5 Y	74.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.44
Assets	INR 194.6M
Cash	INR 14.3M
Current Assets	INR 194.3M
Current Liabilities	INR 100.3M
Debt	INR 33.3M
Debt Equity	INR 0.35
Equity	INR 94.3M
Liabilities	INR 100.3M
Long Term Assets	INR 375,000
Long Term Liabilities	INR 10,000
Net Cash	INR -18.9M
Net Cash By Market Cap	INR -6.81
Net Debt Equity	INR 0.2
Tangible Book Value	INR 94.3M
Tangible Book Value Per Share	INR 14.7
WACC	-8.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.94
Net Working Capital	INR 112.9M
Quick ratio	1.2
Working Capital	INR 94M
Working Capital Turnover	INR 1.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-11.83%
200-day SMA	26.39
50-day SMA	25.15
50-day SMA vs 200-day SMA	50under200
All Time High	36.96
All Time High Change	-35.06%
All Time High Date	2025-08-28
All Time Low	6.27
All Time Low Change	282.78%
All Time Low Date	2024-12-04
ATR	3.1
Beta	-2.4
Beta1y	0.18
Beta2y	0.1
Ch YTD	-3.81
High	24.99
High52	36.96
High52 Date	2025-08-28
High52ch	-35.06%
Low	22.56
Low52	19.01
Low52 Date	2025-10-08
Low52ch	26.25%
Ma50ch	-4.56%
Price vs 200-day SMA	-9.05%
RSI	44.71
RSI Monthly	54.57
RSI Weekly	45.05
Sharpe ratio	0.05x
Sortino ratio	0.17
Total Return	-22.03%
Tr YTD	-3.81
Tr1m	0.08%
Tr1w	-1.32%
Tr3m	-14.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR -1.7M
Operating margin	-3.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,376,810%
Net Borrowing	29,732,000
Shares Insiders	26.81%
Shares Institutions	0.86%
Shares Out	11,582,930
Shares Qo Q	31.56%
Shares Yo Y	22.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,404.7x
Bv Per Share	14.7
Ch1m	0.08
Ch1w	-1.32
Ch1y	-11.83
Ch3m	-14.89
Ch6m	-16.14
Change	-0.25%
Change From Open	0.25
Close	24.06
Days Gap	-0.5
Depreciation Amortization	46,000
Dollar Volume	6,504
Earnings Date	2026-05-14
EBIT	INR -1.7M
EBITDA	INR -1.7M
EPS	INR 1.37
F Score	3
Financing CF	129,743,000
Fiscal Year End	March
Founded	1,988
Graham Number	21.31049
Graham Upside	-11.21
Income Tax	INR 281,000
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2025-12-31
Last Split Date	2009-01-29
Last Split Type	Reverse
Lynch Fair Value	INR 6.87
Lynch Upside	-71.39
Ma150	26.01
Ma150ch	-7.72%
Ma20	25.25
Ma20ch	-4.96%
Net CF	14,250,000
Next Earnings Date	2026-05-14
Open	23.94
Position In Range	59.26
Ppne	375,000
Price Date	2026-05-08
Ptbv Ratio	2.95
Relative Volume	0.19x
Revenue	44,139,000x
Tax By Revenue	0.64x
Tax Rate	3.12%
Tr6m	-16.14%
Volume	271
Z Score	1.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/531015 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/531015 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/531015?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.9%

Share of float held by funds and institutions

Insider ownership

+26.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+22.0%

Negative means the company is buying back shares.

Technical

BOM/531015 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

-2.40

Less volatile than the market

Sharpe ratio

0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/531015

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/531015 stock rating?

bom/531015 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/531015 analysis?

The full report lives at /stocks/bom/531015/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/531015?

The latest report frames bom/531015 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/531015 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.